Login / Signup

Introducing multi-modal enteral medication reduced morbidity and mortality associated with necrotising enterocolitis.

Arman HarutyunyanBerndt UrlesbergerArmen MuradyanMarine HovhannisyanArman BadalyanHrant KalenteryanEmir HaxhijaKarine SargsyanKonstantin YenkoyanAra Babloyan
Published in: Acta paediatrica (Oslo, Norway : 1992) (2020)
The introduction of an enteral multi-modal three-component medication regimen resulted in a significant reduction of mortality and of need for surgical intervention in infants suffering from NEC.
Keyphrases
  • randomized controlled trial
  • healthcare
  • adverse drug
  • cardiovascular events
  • risk factors
  • cardiovascular disease
  • emergency department
  • low birth weight
  • preterm infants